What is Retatrutide used for?
Retatrutide is most commonly used for people plateaued on Tirzepatide; users targeting >15% body weight loss; metabolic-syndrome adults under provider guidance. Triple agonist (GLP-1 + GIP + glucagon) from Eli Lilly. In trials it outperforms Tirzepatide for weight loss. Human evidence for Retatrutide is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use Retatrutide for
- People plateaued on Tirzepatide
- Users targeting >15% body weight loss
- Metabolic-syndrome adults under provider guidance
References
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity (Phase 2) — Jastreboff AM et al., NEJM, 2023
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA — Rosenstock et al., Lancet, 2023
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial — Sanyal et al., Nature Medicine, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Retatrutide
Full Retatrutide breakdownRetatrutide side effectsRetatrutide how to take itRetatrutide mistakes to avoidRetatrutide who should avoid itRetatrutide half-lifeRetatrutide how long to workRetatrutide legal statusRetatrutide how it workscagrilintide vs retatrutideretatrutide vs tirzepatidesemaglutide vs retatrutidevk2735 vs retatrutideAsk the AI Coach
Last updated 2026-06-15.